A drug injury lawsuit is a personal injury case or a wrongful death case involving a serious drug side effect or a severe adverse drug reaction. Here are some of the prescription medications for which drug injury lawsuits were filed against the responsible pharmaceutical company in the first half of 2021: Xeljanz Beovu Elmiron … [Read more...]
There Will Be No Belviq Generic Drugs After Belviq Drug Recall in 2020
There has been some further FDA action regarding Belviq which is related to the 2020 Belviq drug recall that was due to an increased risk of cancer. This further FDA action means there will be no Belviq generic drugs after the Belviq drug recall in 2020. This February 26, 2021 Notice item, “Determination That BELVIQ (Lorcaserin Hydrochloride) … [Read more...]
Some Information About Our Monthly Law Firm Newsletter
The Lamb Law Office Newsletter is a monthly communication from our law firm to help keep you up to date with some of the cases that we are working on for clients at the present time. In addition, we provide at least one information resource item per month, which you or someone you know might find helpful from time to time. Past … [Read more...]
FDA Belviq Recall Decision Came After Safety Data Review Found Excess Cancers Risks
In this FDA staff article, “Cancer risk associated with lorcaserin — The FDA’s review of the CAMELLIA-TIMI 61 trial”, which was published by the New England Journal of Medicine (NEJM), the early 2020 FDA Belviq recall decision was explained. Essentially, this FDA action after a careful analysis of Belviq safety data that revealed excess … [Read more...]
After Drug Recall Belviq Lawsuits Alleging Failure To Warn About Cancer
Following the Belviq recall in February 2020 some of those patients on Belviq developing cancer filed Belviq lawsuits alleging a failure to warn about the risk of cancer associated with Belviq. We are investigating possible Belviq lawsuits that involve patients on Belviq developing cancer. At the present time, our focus for these Belviq lawsuits … [Read more...]
Belviq Recall Due To Certain Cancers: Pancreatic, Colon, Rectal, And Lung
The diet drug Belviq is being withdrawn from the US market because a Belviq safety clinical trial shows an increased occurrence of cancer cases. This February 2020 Belviq FDA Drug Safety Communication announced the Belviq recall, “FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR (lorcaserin) from the market”, and noted that … [Read more...]
Weight-Loss Medicine Belviq Increased Risk Of Cancers Says FDA Drug Safety Communication
UPDATE: "FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR (lorcaserin) from the market" (2-13-2020 FDA Drug Safety Communication) "Potential risk of cancer outweighs the benefits" Imbalances in specific cancers including pancreatic, colorectal, and lung contributed to the observed overall imbalance in cancer … [Read more...]